Evommune EVMN Deferred Offering Cost
Deferred Offering Cost at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:DeferredOfferingCost.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's deferred offering cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's deferred offering cost?
- Evommune (EVMN) reported deferred offering cost of -$577.47K in Q4 2025.
- What does deferred offering cost mean?
- Captures costs incurred in preparation for a planned equity or debt offering that have been capitalized as assets until the offering is completed. Once the offering occurs, these costs are typically reclassified as a reduction of proceeds. Monitoring these costs provides visibility into the company's pipeline for future capital raises.